Micro-scaled method holds promise as improved cancer diagnostic platform
A new-method analyzes the combination of tumor genetic material (genomics) with deep protein and phosphoprotein characterization (proteomics) using a single-needle core biopsy from a patient’s tumor, providing more detailed information about the cancer than conventional approaches.
Read Original Article: Micro-scaled method holds promise as improved cancer diagnostic platform »
